Cargando…
Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study
BACKGROUND: Alternative cancer therapy is associated with increased mortality, but little is known about those who pursue it. OBJECTIVE: We aimed to describe individuals’ motivations for using alternative cancer therapies and determine whether motivations differ based on individuals’ timing of seeki...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214612/ https://www.ncbi.nlm.nih.gov/pubmed/35671074 http://dx.doi.org/10.2196/34183 |
_version_ | 1784731056749936640 |
---|---|
author | Peterson, John Wilson, Trevor Gruhl, Joshua Davis, Sydney Olsen, Jaxon Parsons, Matthew Kann, Benjamin Fagerlin, Angela Watt, Melissa Johnson, Skyler |
author_facet | Peterson, John Wilson, Trevor Gruhl, Joshua Davis, Sydney Olsen, Jaxon Parsons, Matthew Kann, Benjamin Fagerlin, Angela Watt, Melissa Johnson, Skyler |
author_sort | Peterson, John |
collection | PubMed |
description | BACKGROUND: Alternative cancer therapy is associated with increased mortality, but little is known about those who pursue it. OBJECTIVE: We aimed to describe individuals’ motivations for using alternative cancer therapies and determine whether motivations differ based on individuals’ timing of seeking alternative therapies. METHODS: We used data from 649 campaigns posted on the website GoFundMe between 2011 and 2019 for beneficiaries with cancer pursuing alternative therapy. The data were analyzed using a mixed methods approach. Campaigns were categorized by timing of alternative therapy (either before or after experiencing conventional therapy). Qualitative analysis identified motivational themes. Chi-square tests of independence and Fisher tests (all 2-sided) determined significant differences in the presence of motivational themes between groups. RESULTS: The expression of concerns about the efficacy of conventional therapy was significantly more likely in campaigns for individuals who used conventional therapy first than in campaigns for individuals who started with alternative therapy (63.3% vs 41.7%; P<.001). Moreover, on comparing those who started with alternative therapy and those who switched from conventional to alternative therapy, those who started with alternative therapy more often expressed natural and holistic values (49.3% vs 27.0%; P<.001), expressed an unorthodox understanding of cancer (25.5% vs 16.4%; P=.004), referenced religious or spiritual beliefs (15.1% vs 8.9%; P=.01), perceived alternative treatment as efficacious (19.1% vs 10.2%; P=.001), and distrusted pharmaceutical companies (3.2% vs 0.5%; P=.04). CONCLUSIONS: Individuals sought treatments that reflected their values and beliefs, even if scientifically unfounded. Many individuals who reported prior conventional cancer therapy were motivated to pursue alternative treatments because they perceived the conventional treatments to be ineffective. |
format | Online Article Text |
id | pubmed-9214612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-92146122022-06-23 Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study Peterson, John Wilson, Trevor Gruhl, Joshua Davis, Sydney Olsen, Jaxon Parsons, Matthew Kann, Benjamin Fagerlin, Angela Watt, Melissa Johnson, Skyler JMIR Cancer Original Paper BACKGROUND: Alternative cancer therapy is associated with increased mortality, but little is known about those who pursue it. OBJECTIVE: We aimed to describe individuals’ motivations for using alternative cancer therapies and determine whether motivations differ based on individuals’ timing of seeking alternative therapies. METHODS: We used data from 649 campaigns posted on the website GoFundMe between 2011 and 2019 for beneficiaries with cancer pursuing alternative therapy. The data were analyzed using a mixed methods approach. Campaigns were categorized by timing of alternative therapy (either before or after experiencing conventional therapy). Qualitative analysis identified motivational themes. Chi-square tests of independence and Fisher tests (all 2-sided) determined significant differences in the presence of motivational themes between groups. RESULTS: The expression of concerns about the efficacy of conventional therapy was significantly more likely in campaigns for individuals who used conventional therapy first than in campaigns for individuals who started with alternative therapy (63.3% vs 41.7%; P<.001). Moreover, on comparing those who started with alternative therapy and those who switched from conventional to alternative therapy, those who started with alternative therapy more often expressed natural and holistic values (49.3% vs 27.0%; P<.001), expressed an unorthodox understanding of cancer (25.5% vs 16.4%; P=.004), referenced religious or spiritual beliefs (15.1% vs 8.9%; P=.01), perceived alternative treatment as efficacious (19.1% vs 10.2%; P=.001), and distrusted pharmaceutical companies (3.2% vs 0.5%; P=.04). CONCLUSIONS: Individuals sought treatments that reflected their values and beliefs, even if scientifically unfounded. Many individuals who reported prior conventional cancer therapy were motivated to pursue alternative treatments because they perceived the conventional treatments to be ineffective. JMIR Publications 2022-06-07 /pmc/articles/PMC9214612/ /pubmed/35671074 http://dx.doi.org/10.2196/34183 Text en ©John Peterson, Trevor Wilson, Joshua Gruhl, Sydney Davis, Jaxon Olsen, Matthew Parsons, Benjamin Kann, Angela Fagerlin, Melissa Watt, Skyler Johnson. Originally published in JMIR Cancer (https://cancer.jmir.org), 07.06.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on https://cancer.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Peterson, John Wilson, Trevor Gruhl, Joshua Davis, Sydney Olsen, Jaxon Parsons, Matthew Kann, Benjamin Fagerlin, Angela Watt, Melissa Johnson, Skyler Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study |
title | Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study |
title_full | Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study |
title_fullStr | Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study |
title_full_unstemmed | Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study |
title_short | Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study |
title_sort | timing and motivations for alternative cancer therapy with insights from a crowdfunding platform: cross-sectional mixed methods study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214612/ https://www.ncbi.nlm.nih.gov/pubmed/35671074 http://dx.doi.org/10.2196/34183 |
work_keys_str_mv | AT petersonjohn timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy AT wilsontrevor timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy AT gruhljoshua timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy AT davissydney timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy AT olsenjaxon timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy AT parsonsmatthew timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy AT kannbenjamin timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy AT fagerlinangela timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy AT wattmelissa timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy AT johnsonskyler timingandmotivationsforalternativecancertherapywithinsightsfromacrowdfundingplatformcrosssectionalmixedmethodsstudy |